The impact of Heparin Binding - Epidermal growth factor-like growth factor (HB-EGF) on oocyte quality in women undergoing ICSI and its potential contribution to environmental diversity
DOI:
https://doi.org/10.5281/zenodo.10206869Keywords:
HB-EGF, ICSI, oocyte qualityAbstract
Oocyte quality refers to the health and developmental potential of an egg cell (oocyte) in the context of reproductive processes. Oocyte quality is a critical factor in successful fertilization and subsequent embryo development. Heparin-binding EGF-like growth factor is known by its acronym, HB-EGF. It belongs to the protein family known as epidermal growth factor (EGF). Cell-signalling protein HB-EGF is involved in proliferation, differentiation, growth, and tissue repair among other physiological activities. In Reproductive Biology: HB-EGF has been studied in the context of reproductive biology, particularly in processes related to fertility and embryonic development. For example, it has been investigated for its role in improving blastocyst development in assisted reproductive technologies. This study aimed to analyze the correlation between follicular fluid and serum HB-EGF with oocyte quality, 44 women with Polycystic ovary syndrome (PCOS) and unexplained infertility underwent IVF cycle in the form of intra-cytoplasm sperm injection ICSI enrolled in the study, follicular fluid and serum were collected from patients at oocyte retrieval day, HB-EGF levels measured by ELISA. From 44 women, HB-EGF has no correlation with all oocyte characteristics p-value >0.05 except with damaged oocyte number, follicular fluid, and serum HB-EGF had significant positive correlation p-value= 0.428,0.357 respectively. An article found that follicular fluid and serum HB-EGF had a positive correlation with the fragile oocyte.
References
Dashti, S., & Eftekhar, M. (2021). Luteal-phase support in assisted reproductive technology: An ongoing challenge. International Journal of Reproductive BioMedicine, 19(9), 761–772. https://doi.org/10.18502/ijrm.v19i9.9708.
Elliott, A. C., & Woodward, W. A. (2007). Statistical analysis quick reference guidebook. SAGE Publications, Inc., https://doi.org/10.4135/9781412985949.
Gilchrist, R. B., Lane, M., & Thompson, J. G. (2008). Oocyte-secreted factors: Regulators of cumulus cell function and oocyte quality. Human Reproduction Update, 14(2), 159–177. https://doi.org/10.1093/humupd/dmm040.
Hammadeh, M. E., Fischer-Hammadeh, C., Amer, A. S., Rosenbaum, P., & Schmidt, W. (2005). Relationship between cytokine concentration in serum and preovulatory follicular fluid and in vitro fertilization/intracytoplasmic sperm injection outcome. Immunology of Gametes and Embryo Implantation, 88, 80-97. https://doi.org/10.1159/000187822.
Hu, X., Liu, Y., Zhang, X., Lee, P., Wen, Y., Ding, C., Zhou, C., & Xu, Y. (2021).
Oocyte Degeneration After ICSI Is Not an Indicator of Live Birth in Young Women.
Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.705733.
Huang, J. C., Duan, C. C., Jin, S., Sheng, C. B., Wang, Y. S., Yue, Z. P., & Guo, B. (2022).
HB-EGF induces mitochondrial dysfunction via estrogen hypersecretion in granulosa cells dependent on cAMP-PKA-JNK/ERK-Ca2+-FOXO1 pathway.International Journal of Biological Sciences, 18(5), 2047–2059. https://doi.org/10.7150%2Fijbs.69343.
Martin, K. L., Barlow, D. H., & Sargent, I. L. (1998). Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium. Human Reproduction (Oxford, England), 13(6), 1645-1652. https://doi.org/10.1093/humrep/13.6.1645.
Mizobe, Y., Oya, N., Iwakiri, R., Yoshida, N., Sato, Y., Onoue, N., ... & Ezono, Y. (2016). Developmental ability of embryos produced from oocytes with fragile oolemma by intracytoplasmic sperm injection. Journal of assisted reproduction and genetics, 33, 1685-1690. https://doi.org/10.1007/s10815-016-0811-4.
Nikbakht, R., Mohammadjafari, R., Rajabalipour, M., & Moghadam, M. T. (2021). Evaluation of oocyte quality in Polycystic ovary syndrome patients undergoing ART cycles. Fertility research and practice, 7, 1-6. https://doi.org/10.1186/s40738-020-00094-z.
Ozbilgin, K., Karaca, F., Turan, A., Köse, C., Vatansever, S., & Ozcakir, T. (2015). The higher heparin-binding epidermal growth factor (HB-EGF) in missed abortion. Taiwanese Journal of Obstetrics and Gynecology, 54(1), 13-18. https://doi.org/10.1016/j.tjog.2013.08.011.
Raab, G., & Klagsbrun, M. (1997). Heparin-binding EGF-like growth factor. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1333(3), F179-F199.
https://doi.org/10.1016/S0304-419X(97)00024-3.
Sciorio, R., Miranian, D., & Smith, G. D. (2022). Non-invasive oocyte quality assessment. Biology of Reproduction, 106(2), 274-290. https://doi.org/10.1093/biolre/ioac009.
Sun, X. X., Gemzell-Danielsson, K., Li, H. Z., Stâbi, B., & Stavreus-Evers, A. (2006). Expression of heparin-binding epidermal growth factor–like growth factor and its receptors in the human fallopian tube and endometrium after treatment with mifepristone. Fertility and sterility, 85(1), 171-178. https://doi.org/10.1016/j.fertnstert.2005.08.011.
Sutaji, Z., Abu, M. A., Sayutti, N., Elias, M. H., Ahmad, M. F., Nur Azurah, A. G., ... & Hussein, Z. A. M. (2023). Endometrial Heparin-Binding Epidermal Growth Factor Gene Expression and Hormone Level Changes in Implantation Window of Obese Women with Polycystic Ovarian Syndrome. Biomedicines, 11(2), 276. https://doi.org/10.3390/biomedicines11020276.
JWB applies the 